A trial looking at using chemotherapy, a cancer vaccine and chemoembolisation for liver cancer (ImmunoTACE)

Overview

Cancer types:

Liver cancer

Status:

Results

Phase:

Phase 2

Details

This trial looked at chemotherapy and with or without a . It was for people with liver cancer that had not spread to another part of the body.

People could join the trial between 2016 and 2019. The team published the results in 2025.

Recruitment start: 24 March 2016

Recruitment end: 9 October 2019

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Professor David Adams

Supported by

Experimental Cancer Medicine Centre (ECMC)

NIHR Efficacy and Mechanism Evaluation (EME) Programme

University of Birmingham

Last reviewed: 05 Oct 2026

CRUK internal database number: 9660

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Find a Clinical Trial

Search our clinical trials database for all cancer trials and studies recruiting in the UK.

An icon of two speech bubbles, indicating a conversation.

Cancer Chat forum

Connect with other people affected by cancer and share your experiences.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.